関連する実験動画
Updated: Aug 8, 2026
13:39
Protocol for Production of a Genetic Cross of the Rodent Malaria Parasites
Published on: January 3, 2011
薬剤耐性移転に関連した変異性ダイヒドロフォラート還元酵素は,ネズミのプラズモジア間の薬剤耐性移転に関連しています
Science (New York, N.Y.)
|February 27, 1970
まとめ
プラズモディウム寄生虫の薬剤耐性は,ダイヒドロフォラート還元酵素の変化と関連しています. 耐性のあるPlasmodium berghei菌株は,おそらくPlasmodium vinckeiからの遺伝子移植によって,ピリメタミンに対する耐性を獲得した.
科学分野:
- マラリアに関する研究.
- 寄生虫学とは,寄生虫学である.
- 分子生物学は分子生物学である.
背景:
- プラズモディウム寄生虫のピリメタミン耐性については,懸念が高まっている.
- ディヒドロフォラート還元酵素 (DHFR) は,葉酸代謝の重要な酵素であり,抗マラリア薬の標的である.
- DHFRの量と性質の変化は,ピリメタミン抵抗と関連しています.
研究 の 目的:
- プラズモディアム・ベルゲイ (Plasmodium berghei) のピリメタミン抵抗性のメカニズムを調査する.
- マラリア寄生虫における薬剤耐性を獲得するメカニズムとして遺伝子転送の可能性を調査する.
主な方法:
- ハムスターにおける薬剤耐性プラズモディウム・ビンケイと薬剤敏感プラズモディウム・ベルゲイによる混合感染症の実験誘導.
- 耐性プラズモディアム・ベルゲイ菌株を隔離するための生物学的濾過.
- 耐性菌株と敏感菌株における二水酸化葉酸還元酵素 (DHFR) の分析.
主要な成果:
- Plasmodium bergheiの耐性菌株が成功裏に分離されました.
- 耐性プラズモディウム・ベルゲイは,変化したDHFRの量と性質を示した.
- 薬剤耐性の獲得は,Plasmodium vinckei.から遺伝子の移転によって,証拠が示唆しています.
結論:
- 遺伝子転送は,抗マラリア薬剤耐性の出現と拡散に重要な役割を果たす可能性があります.
- これらのメカニズムを理解することは,薬剤耐性マラリアとの闘いの戦略を策定する上で極めて重要です.
- プラズモジアの水平遺伝子転送に関するさらなる研究が必要である.
関連する概念動画
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:27Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...
01:27Diversity of Protists II
Alveolates are a group of organisms recognized by the presence of alveoli, which are cytoplasmic sacs located beneath the cell membrane. While their function remains uncertain, alveoli may help regulate water balance by controlling how much water enters and leaves the cell. In dinoflagellates, these structures may serve as armor plates. There are three major types of alveolates: ciliates, which move using cilia; dinoflagellates, which use flagella for movement; and apicomplexans, which are...
01:29Malaria
Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
01:15Anthelminthic Agents
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
01:21Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...